stay updated with our newsletter

David Haase, MD: Navigating the Intersections of Stress, Pain, and Addiction – Seeing Hope through the Functional Medicine Lens

David Haase on Stress, Pain, and Addiction
In this interview by Craig Gustafson, he talks with David Haase, MD, the keynote speaker at the Institute for Functional Medicine Annual International Conference, 2019. Originally published in Integrative Medicine, A Clinician’s Journal, Dr. Haase discusses the issue of  stress, pain, and addiction. The following is an excerpt followed by

Read more

Researchers Identify Biomarker Blood Test to Measure Pain

A breakthrough test developed by Indiana University School of Medicine researchers to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation. A study led by psychiatry professor Alexander Niculescu, MD, PhD and published in Nature journal Molecular PsychiatryRead

Low-Level Laser Therapy as a Non-Pharma Option for Chronic Pain and Osteoarthritis

As the pressure to adopt non-pharma solutions for chronic pain become more imperative, integrative providers are looking at low-level laser therapy as a viable option. Low-level laser therapy (LLLT) is a form of light therapy that triggers biochemical changes within cells. Photons are absorbed by cellular photoreceptors, triggering chemical alterations

Read more

Webinar: Drs. Vanila Singh and Shari Ling on the HHS Pain Management Best Practices Inter-Agency Task Force

pain management

It’s no secret that there is an opioid addiction crisis in this country and that opioid prescriptions have played a role in this epidemic. To the integrative health community, it’s also no secret that part of the solution lies with integrative pain management protocols. What you may not know isRead

Inclusion Check-in: Are Integrative Practices in New Federal Opioid Legislation, National Academy, and FDA Activity?

One can easily count the chickens of non-pharmacological approaches highlighted in multiple organizational guidelines and state strategies related to pain and opioids. But one definitely cannot count on them hatching inside each new, significant policy initiative. Regular medicine tends to regress toward a non-inclusive mean in pain treatment. And “mean”Read

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.